By: Kairos Ventures On: February 23, 2021 In: Portfolio News, Provivi

Small scale producers in developing countries to benefit from an agreement between Provivi and the Bill & Melinda Gates...

Read more
By: Kairos Ventures On: February 15, 2021 In: Portfolio News, Xidas

The EHM-UNIV from Xidas is a small floor mount power harvesting and energy administration module that eliminates the necessity...

Read more
By: Kairos Ventures On: February 7, 2021 In: Portfolio News, Xidas

Xidas Inc., introduces a small high-pulse rechargeable battery with an operating temperature range of -40°C to +85°C that eliminates...

Read more
By: Kairos Ventures On: February 4, 2021 In: Novosteo, Portfolio News

Novosteo Inc., announced the closing of a $5.5 million in Series A financing to advance its development of the...

Read more
By: Kairos Ventures On: February 2, 2021 In: MixComm, Portfolio News

MixComm is sponsoring the mmWave Summit webinar, the first in a new series that will highlight recent mmWave advances...

Read more
By: Kairos Ventures On: February 1, 2021 In: Portfolio News, Provivi

Provivi® Inc proudly announces regulatory approval of “PherogenTM SPOFR” in Kenya. The authorization issued by Kenya’s Pest Control Products...

Read more
By: Kairos Ventures On: January 28, 2021 In: Foldax, Portfolio News

Foldax has announced the publication of a research paper in Advanced NanoBiomed Research that concluded that its LifePolymer biopolymer...

Read more
By: Kairos Ventures On: January 14, 2021 In: MemVerge, Portfolio News

Seeing the potential for persistent memory, MemVerge was launched to realize this potential. MemVerge is attempting to blend the...

Read more
By: Kairos Ventures On: January 13, 2021 In: MixComm, Portfolio News

EverythingRF rewards MixComm another top 10 product of 2020 honor for their flagship product SUMMIT2629™, a beamforming front end...

Read more
By: Kairos Ventures On: January 12, 2021 In: Linnaeus, Portfolio News

Launched at Penn’s UPstart incubator, Haddonfield’s Linnaeus Therapeutics is in the early stages of clinical trials for an anti-cancer...

Read more